Literature DB >> 24793648

Risk factors for mortality and failure of conservative treatment after aortic type B dissection.

Jochen Grommes1, Andreas Greiner2, Bianca Bendermacher3, Max Erlmeier4, Andreas Frech4, Perrine Belau2, Lieven N Kennes5, Gustav Fraedrich4, Geert Wilhelm Schurink6, Michael J Jacobs7, Josef Klocker4.   

Abstract

BACKGROUND: Despite medical treatment, one third of patients with uncomplicated type B aortic dissections experience severe late complications. The aim of this study was to identify patients at high risk of mortality during follow-up.
METHODS: A total of 183 patients with acute Stanford type B dissection were treated in one of the university hospitals (Aachen [Germany], Maastricht [The Netherlands], and Innsbruck [Austria]) between 1997 and 2010. Records indicated that 120 patients were treated conservatively. Of these patients, 16 were lost to follow-up. The maximum diameter, extent of the dissection, and patency of the side branches were determined from computed tomography angiography data. Survival and treatment failure were analyzed by univariate and multivariate Cox regression analysis. The univariate analysis investigated the influence of aortic diameter (≥41 vs <41 mm) on survival, and the multivariate analysis investigated the influence of aortic diameter, age, sex, and surgery on survival.
RESULTS: During the follow-up period, the initial treatment was converted to surgical treatment in 21 patients (20.2%). Sixteen of the 104 patients (15.4%) died after a mean of 845.5±805.9 days. The mean maximum aortic transversal diameter at admission was 41.2±8.7 mm. The multivariate analysis identified aortic diameter (P=.004; hazard ratio, 1.07) and age (P=.038; hazard ratio, 1.05) as risk factors that significantly reduce survival.
CONCLUSIONS: Our study revealed both early aortic dilatation and older age as risk factors for increased mortality after conservative treatment of type B dissection.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24793648     DOI: 10.1016/j.jtcvs.2014.03.053

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Left ventricular hypertrophy is a possible biomarker for early mortality after type B aortic dissection.

Authors:  Alexander P Taylor; Rosario V Freeman; Matthew A Bartek; Sherene Shalhub
Journal:  J Vasc Surg       Date:  2018-12-11       Impact factor: 4.268

2.  Computed Tomography Imaging Features in Acute Uncomplicated Stanford Type-B Aortic Dissection Predict Late Adverse Events.

Authors:  Anna M Sailer; Sander M J van Kuijk; Patricia J Nelemans; Anne S Chin; Aya Kino; Mark Huininga; Johanna Schmidt; Gabriel Mistelbauer; Kathrin Bäumler; Peter Chiu; Michael P Fischbein; Michael D Dake; D Craig Miller; Geert Willem H Schurink; Dominik Fleischmann
Journal:  Circ Cardiovasc Imaging       Date:  2017-04       Impact factor: 7.792

Review 3.  Type B Aortic Dissection: A Review of Prognostic Factors and Meta-analysis of Treatment Options.

Authors:  Thomas Luebke; Jan Brunkwall
Journal:  Aorta (Stamford)       Date:  2014-12-01

4.  Predictors of Failure of Medical Management in Uncomplicated Type B Aortic Dissection.

Authors:  Xiaoying Lou; Yazan M Duwayri; Edward P Chen; William D Jordan; Jessica Forcillo; Carl A Zehner; Bradley G Leshnower
Journal:  Ann Thorac Surg       Date:  2018-10-04       Impact factor: 4.330

5.  Outcomes of Patients With Acute Type B (DeBakey III) Aortic Dissection: A 13-Year, Single-Center Experience.

Authors:  Rana O Afifi; Harleen K Sandhu; Samuel S Leake; Mina L Boutrous; Varsha Kumar; Ali Azizzadeh; Kristofer M Charlton-Ouw; Naveed U Saqib; Tom C Nguyen; Charles C Miller; Hazim J Safi; Anthony L Estrera
Journal:  Circulation       Date:  2015-08-25       Impact factor: 29.690

6.  The new indication of TEVAR for uncomplicated type B aortic dissection.

Authors:  Chao Song; Qingsheng Lu; Jian Zhou; Guanyu Yu; Xiang Feng; Zhiqing Zhao; Junmin Bao; Rui Feng; Zaiping Jing
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.